|
|
| Zeile 16: |
Zeile 16: |
| | | | |
| | *'''[[Respiration mgmt]]''' | | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=C7203031|t=ä. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection? |pdf=|usr=}}
| |
| − | {{tp|p=C7144845|t=ä. Cuidado respiratorio en COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32392023|t=2020. Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations |pdf=|usr=}}
| |
| − | {{tp|p=C7179052|t=2020. Barrier System for Airway Management of COVID-19 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32446500|t=ä. Ultra-portable low-cost improvised powered air-purifying respirator: feasibility study |pdf=|usr=}}
| |
| − | {{tp|p=32414510|t=ä. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis |pdf=|usr=}}
| |
| − | {{tp|p=32377387|t=2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 28: |
Zeile 21: |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
| |
| − | {{tp|p=C7169335|t=2020. Promising methods for detection of novel coronavirus SARS?CoV?2 |pdf=|usr=}}
| |
| − | {{tp|p=C7144506|t=2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) |pdf=|usr=}}
| |
| − | {{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=32387093|t=2020. Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences |pdf=|usr=}}
| |
| − | {{tp|p=32382418|t=2020. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32386880|t=ä. ...de las lesiones pulmonares |pdf=|usr=}}
| |
| − | {{tp|p=32381057|t=2020. CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method |pdf=|usr=}}
| |
| − | {{tp|p=32416069|t=ä. Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography |pdf=|usr=}}
| |
| − | {{tp|p=C7202857|t=2020. COVID-19 detection using deep learning models to exploit Social Mimic Optimization and structured chest X-ray images using fuzzy color and stacking approaches |pdf=|usr=}}
| |
| − | {{tp|p=C7190523|t=2020. Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks |pdf=|usr=}}
| |
| − | {{tp|p=C7187882|t=2020. Automated detection of COVID-19 cases using deep neural networks with X-ray images |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 74: |
Zeile 53: |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32377375|t=2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing |pdf=|usr=}}
| |
| − | {{tp|p=32407669|t=ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32382126|t=ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients |pdf=|usr=}}
| |
| − | {{tp|p=32382127|t=ä. NKG2A and COVID-19: another brick in the wall |pdf=|usr=}} ''we dont need no isolation we dont need no folks control''
| |
| − | {{tp|p=32235915|t=ä. COVID-19: a new challenge for human beings |pdf=|usr=}}
| |
| − | {{ttp|p=32203188|t=ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |pdf=|usr=}}
| |
| − | {{ttp|p=32203186|t=ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32132669|t=ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV |pdf=|usr=}}
| |
| − | {{tp|p=C7064018|t=ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 92: |
Zeile 61: |
| | ---- | | ---- |
| | *'''[[Pathobiology]]''' | | *'''[[Pathobiology]]''' |
| − | {{tp|p=C7173822|t=2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study |pdf=|usr=}}
| |
| − | {{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}}
| |
| − | {{tp|p=32434133|t=2020. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities |pdf=|usr=}}
| |
| − | {{ttp|p=32314313|t=ä. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}} ''After studying the published clinical reports, what surprised me is that most patients who had the most severe complications were affected by two comorbidities (or their long-term effects): hypertension and diabetes. Both of them induce, among other problems, '''chronic stress on endothelial cells''' that in turn can express molecules on their plasma membranes abnormally... ...In turn, these autoimmune reactions against endothelium can generate thrombosis, disseminated intravascular coagulation and multi-organ failure.''
| |
| | | | |
| | | | |
| Zeile 130: |
Zeile 95: |
| | | | |
| | *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32389704|t=ä. Pain: A potential new label of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32387508|t=ä. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis |pdf=|usr=}}
| |
| − | {{tp|p=32387343|t=ä. SARS-CoV-2: ?Three-steps? infection model and CSF diagnostic implication |pdf=|usr=}}
| |
| − | {{tp|p=32387342|t=ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32389893|t=2020. Coronavirus disease 2019 (COVID-19) in neurology and neurosurgery: A scoping review of the early literature |pdf=|usr=}}
| |
| − | {{tp|p=32390789|t=2020. Schlaganfälle und Enzephalitis bei COVID-19?|pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 158: |
Zeile 116: |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32387167|t=ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32387456|t=ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) |pdf=|usr=}}
| |
| − | {{tp|p=32402433|t=ä. Child with liver transplant recovers from COVID-19 infection A case report |pdf=|usr=}}
| |
| − | {{tp|p=32376395|t=2020. SARS-CoV-2 infection among patients with systemic autoimmune diseases |pdf=|usr=}}
| |
| − | {{tp|p=32376969|t=ä. COVID-19 outcomes in patients with hematologic disease |pdf=|usr=}}
| |
| − | {{tp|p=32386820|t=ä. Evidence of mother-to-newborn infection with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32381262|t=ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission |pdf=|usr=}}
| |
| − | {{tp|p=32389618|t=ä. An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report |pdf=|usr=}}
| |
| − | {{tp|p=32382516|t=2020. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 192: |
Zeile 139: |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32387535|t=ä. Asthma, biologics, corticosteroids, and coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{ttp|p=C7197610|t=ä. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy |pdf=|usr=}}
| |
| − | {{tp|p=C7197606|t=ä. Antibody therapies for the treatment of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32376396|t=2020. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?|pdf=|usr=}}
| |
| − | {{tp|p=32380316|t=2020. Convalescent plasma in Covid-19: Possible mechanisms of action |pdf=|usr=}}
| |
| − | {{tp|p=32380318|t=2020. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32380315|t=2020. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis |pdf=|usr=}}
| |
| − | {{tp|p=32376392|t=2020. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |pdf=|usr=}}
| |
| − | {{tp|p=32387040|t=ä. Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?|pdf=|usr=}}
| |
| − | {{tp|p=32389697|t=ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series |pdf=|usr=}}
| |
| − | {{tp|p=32475597|t=2020. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32437659|t=2020. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection |pdf=|usr=}}
| |
| − | {{ttp|p=32402856|t=2020. Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?|pdf=|usr=}}
| |
| − | {{ttp|p=32231345|t=ä. Inhibition of SARS-CoV-2 infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |pdf=|usr=}}''Here we generated a series of lipopeptides derived from EK1 and found that EK1C4 was the most potent fusion inhibitor against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection''
| |
| − | {{tp|p=32376238|t=2020. (rev on nat.prod.pharmacophores)Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective |pdf=|usr=}}
| |
| − | {{tp|p=32391065|t=2020. Traditional Chinese medicine contributes to the treatment of COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32402416|t=ä. Perforacion intestinal en paciente COVID-19 en tratamiento con tocilizumab y corticoides ... |pdf=|usr=}}
| |
| − | {{tp|p=C7186126|t=ä. Proposed use of thalidomide for the cytokine storm of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32379639|t=2020. Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines |pdf=|usr=}}
| |
| − | {{tp|p=32379692|t=2020. Traditional Chinese Medicine treatment of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7151553|t=2020. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles? heel conserved region to minimize probability of escape mutations and drug resistance |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| | {{tp|p=32376320|t=ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract |pdf=|usr=}} | | {{tp|p=32376320|t=ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract |pdf=|usr=}} |
| Zeile 224: |
Zeile 149: |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=C7147274|t=ä. Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating 2019-nCoV Infection |pdf=|usr=}}
| |
| − | {{tp|p=C7148653|t=2020. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents |pdf=|usr=}}
| |
| − | {{tp|p=32389627|t=ä. Application of fluorescence method in the process of personal protective equipment removal |pdf=|usr=}}
| |
| − | {{tp|p=32409144|t=ä. A Review of Current Interventions for COVID-19 Prevention |pdf=|usr=}}
| |
| − | {{tp|p=32448491|t=ä. A Reusable Mask for Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=C7155949|t=ä. Common breaches in biosafety during donning and doffing of protective personal equipment used in the care of COVID-19 patients |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32409243|t=2020. ... oftalmologica ... |pdf=|usr=}}
| |
| − | {{tp|p=32416531|t=2020. Handling the COVID-19 pandemic: Proposing a community based toolkit for psycho-social management and preparedness |pdf=|usr=}}
| |
| − | {{tp|p=32442894|t=2020. Pandemics and psychiatry: Repositioning research in context of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32403025|t=2020. Online mental health services in Indonesia during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32473537|t=2020. Why all COVID-19 hospitals should have mental health professionals: The importance of mental health in a worldwide crisis!|pdf=|usr=}}
| |
| − | {{tp|p=32416532|t=2020. Working in the emergency and inpatient COVID-19 special wards: A different experience for Iranian psychiatric trainees amid the outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32380441|t=2020. Psychological interventions during COVID-19: Challenges for low and middle income countries |pdf=|usr=}}
| |
| − | {{tp|p=32402477|t=2020. Telemedicine in the face of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32386927|t=2020. Enfermedad por coronavirus 2019 (COVID-19) en Am�rica Latina: papel de la atenci�n primaria en la preparaci�n y respuesta |pdf=|usr=}}
| |
| − | {{tp|p=32376399|t=2020. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |pdf=|usr=}}
| |
| − | {{tp|p=32380317|t=2020. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?|pdf=|usr=}}
| |
| − | {{tp|p=C7180632|t=2020. OMFS and ENT surgeons issue new COVID-19 PPE guidance |pdf=|usr=}}
| |
| − | {{tp|p=32416987|t=ä. Rapid training of healthcare staff for protected cardiopulmonary resuscitation in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32416989|t=ä. Failure modes and effect analysis to develop transfer protocols in the management of COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32386832|t=ä. Prevention is better than the cure, but the cure cannot be worse than the disease: fibreoptic tracheal intubation in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32386837|t=ä. Percutaneous tracheostomy in patients with COVID-19: sealing the bronchoscope with an in-line suction sheath |pdf=|usr=}}
| |
| − | {{tp|p=32386835|t=ä. The Airway Lead: opportunities to improve institutional and personal preparedness for airway management |pdf=|usr=}}
| |
| − | {{tp|p=32416988|t=ä. Minimising droplet and virus spread during and after tracheal extubation |pdf=|usr=}}
| |
| − | {{tp|p=32386834|t=ä. A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32386833|t=ä. Considerations for resuscitation and transfer of paediatric patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32402375|t=ä. Modified tracheal extubation for patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32376006|t=ä. Rational perioperative utilisation and management during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32381261|t=ä. Equality or utility? Ethics and law of rationing ventilators |pdf=|usr=}}
| |
| − | {{tp|p=32417018|t=ä. A perspective from a NYC chief oral and maxillofacial surgery resident during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32418760|t=ä. Aerosol prevention in osteosynthesis for maxillofacial trauma ? a technical note |pdf=|usr=}}
| |
| − | {{tp|p=32386671|t=ä. Management in oral and maxillofacial surgery during the COVID-19 pandemic: Our experience |pdf=|usr=}}
| |
| − | {{tp|p=32390668|t=2020. Social Work in the Time of the COVID-19 Pandemic: All in This Together?|pdf=|usr=}}
| |
| − | {{tp|p=32416925|t=ä. ...cancer du sein ... |pdf=|usr=}}
| |
| − | {{tp|p=32387061|t=ä. COVID-19 and acute lymphoblastic leukemias of children and adolescents: ... |pdf=|usr=}}
| |
| − | {{tp|p=32387062|t=ä. ...et cancer en France... |pdf=|usr=}}
| |
| − | {{tp|p=C7192084|t=ä. Multidisciplinary management of the burn injured patient during a pandemic -? The role of telemedicine |pdf=|usr=}}
| |
| − | {{tp|p=32381447|t=2020. The role of enzymatic debridement in burn care in the COVID-19 pandemic Commentary by the Italian Society of Burn Surgery (SIUST) |pdf=|usr=}}
| |
| − | {{tp|p=C7180154|t=ä. COVID-19 pandemic and the burn survivor community: A call for action? |pdf=|usr=}}
| |
| − | {{tp|p=32416984|t=ä. Burn center function during the COVID-19 pandemic: An international multi-center report of strategy and experience |pdf=|usr=}}
| |
| − | {{tp|p=32381449|t=2020. Management strategies for the burn ward during COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7155950|t=ä. Social distancing: implications for the operating room in the face of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32380228|t=ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Societies |pdf=|usr=}}
| |
| − | {{tp|p=32376346|t=ä. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions |pdf=|usr=}}
| |
| − | {{tp|p=32454025|t=ä. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer |pdf=|usr=}}
| |
| − | {{tp|p=32389580|t=2020. Radiotherapie mammaire ... |pdf=|usr=}}
| |
| − | {{tp|p=32391172|t=2020. Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32439139|t=ä. Atenci�n de la urgencia quir�rgica durante la pandemia COVID-19 Recomendaciones de la Asociaci�n Espa�ola de Cirujanos |pdf=|usr=}}
| |
| − | {{tp|p=C7184441|t=ä. ERA-EDTA sharing Milan experience on coronavirus management in dialysis centres |pdf=|usr=}}
| |
| − | {{tp|p=32388156|t=2020. EEG during the COVID-19 pandemic: What remains the same and what is different |pdf=|usr=}}
| |
| − | {{tp|p=32382877|t=ä. Notfällige Neurointerventionen, Covid-19 und Thorax-CT: SOP und Literaturäbersicht |pdf=|usr=}}
| |
| − | {{tp|p=32418675|t=2020. Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32389318|t=2020. Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic ? Rapid Review |pdf=|usr=}}
| |
| − | {{tp|p=32382932|t=ä. COVID-19: a novel coronavirus and a novel challenge for oral healthcare |pdf=|usr=}}
| |
| − | {{ttp|p=32392488|t=2020. Transmission of coronavirus by nebulizer: a serious, underappreciated risk |pdf=|usr=}}
| |
| − | {{tp|p=C7170009|t=ä. Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit |pdf=|usr=}}
| |
| − | {{tp|p=32388123|t=2020. How to manage obsessive-compulsive disorder (OCD) under COVID-19:...|pdf=|usr=}}
| |
| − |
| |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| | | | |
| Zeile 317: |
Zeile 183: |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32387346|t=ä. Home quarantine or centralized quarantine, which is more conducive to fighting COVID-19 pandemic?|pdf=|usr=}}
| |
| − | {{tp|p=32386545|t=2020. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States |pdf=|usr=}}
| |
| − | {{ttp|p=32392510|t=2020. Open access epidemiologic data and an interactive dashboard to monitor the COVID-19 outbreak in Canada |pdf=|usr=}}
| |
| − | {{tp|p=32341718|t=ä. Prediction of numbers of the accumulative confirmed patients (NACP) and the plateau phase of 2019-nCoV in China |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 349: |
Zeile 211: |
| | | | |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32387041|t=ä. COVID-19 and Moral Imperialism in Multinational Clinical Research |pdf=|usr=}}
| |
| − | {{tp|p=32381375|t=ä. Tackling the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7204330|t=2020. Introduction to Artificial Intelligence in Economics and Finance Theories |pdf=|usr=}}
| |
| − | {{tp|p=C7152373|t=2007. Other Viral, Bacterial, Parasitic and Prion-Based Infectious Complications |pdf=|usr=}}
| |
| − | {{tp|p=32375806|t=2020. Reappraisal on pharmacological and mechanical treatments of heart failure |pdf=|usr=}}
| |
| − | {{tp|p=C7182114|t=1971. Remarks on the Classification of Viruses |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
